EP2395984
PHARMACEUTICAL COMPOSITION COMPRISING LINAGLIPTIN AND A SGLT2 INHIBITOR,AND USES THEREOF
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
11.2.2010EP published:
19.10.2016EP application number:
10703474.6
EPO information:
European Patent Register
Max expiry date:
10.2.2030
Title:
PHARMACEUTICAL COMPOSITION COMPRISING LINAGLIPTIN AND A SGLT2 INHIBITOR,AND USES THEREOF
Timeline
Today
11.2.2010EP application
19.10.2016EP Publication
Owner
Name:
Boehringer Ingelheim International GmbHAddress:
Binger Strasse 173, 55216, Ingelheim, DE
Inventor
Name:
EISENREICH, WolframAddress:
Ingelheim Am Rhein, DE
Priority
Number:
152306 PDate:
13.2.2009Country:
US
Classification
Categories:
A61P 3/06, A61P 3/08, A61P 3/10, A61K 31/522, A61K 31/7048, A61K 9/20, A61K 9/36